IRIS
CORRADO, ADDOLORATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.381
EU - Europa 6.005
AS - Asia 4.524
SA - Sud America 751
Continente sconosciuto - Info sul continente non disponibili 735
AF - Africa 84
OC - Oceania 12
Totale 22.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.235
CN - Cina 1.653
IE - Irlanda 1.579
SG - Singapore 1.574
RU - Federazione Russa 1.019
UA - Ucraina 1.008
SE - Svezia 747
BR - Brasile 611
HK - Hong Kong 463
FR - Francia 401
IT - Italia 317
VN - Vietnam 293
DE - Germania 292
FI - Finlandia 182
GB - Regno Unito 144
IN - India 119
TR - Turchia 118
CZ - Repubblica Ceca 98
BD - Bangladesh 85
CA - Canada 70
AR - Argentina 53
IQ - Iraq 43
PL - Polonia 40
MX - Messico 37
AT - Austria 34
BE - Belgio 30
EC - Ecuador 26
NL - Olanda 26
ZA - Sudafrica 21
JP - Giappone 20
ID - Indonesia 19
UZ - Uzbekistan 18
ES - Italia 15
VE - Venezuela 14
EG - Egitto 12
LT - Lituania 12
PK - Pakistan 12
JO - Giordania 11
PY - Paraguay 11
CL - Cile 10
CO - Colombia 10
IR - Iran 10
SA - Arabia Saudita 10
JM - Giamaica 9
MA - Marocco 9
PE - Perù 9
DK - Danimarca 8
EU - Europa 8
RO - Romania 8
TN - Tunisia 8
AZ - Azerbaigian 7
CR - Costa Rica 7
PH - Filippine 7
SN - Senegal 7
CH - Svizzera 6
KE - Kenya 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
AU - Australia 5
CI - Costa d'Avorio 5
LB - Libano 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
HR - Croazia 4
IL - Israele 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NG - Nigeria 4
NP - Nepal 4
OM - Oman 4
PR - Porto Rico 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
MN - Mongolia 3
MY - Malesia 3
PA - Panama 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AM - Armenia 2
BY - Bielorussia 2
GT - Guatemala 2
HN - Honduras 2
KR - Corea 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 21.743
Salva come PNG Salva come JPEG
Città #
Dallas 1.833
Dublin 1.576
San Jose 1.413
Singapore 784
Chandler 713
Jacksonville 660
Nyköping 500
Hong Kong 456
Dearborn 455
Ashburn 451
Beijing 398
Nanjing 300
Santa Clara 251
Council Bluffs 217
Columbus 199
Lauterbourg 188
Princeton 165
Wilmington 158
Munich 132
The Dalles 124
Los Angeles 123
Moscow 118
New York 109
Ho Chi Minh City 105
Nanchang 95
San Mateo 90
Helsinki 87
Brno 79
Ann Arbor 77
Boardman 77
Shenyang 73
Phoenix 68
Hanoi 61
São Paulo 56
Des Moines 53
Tianjin 49
Atlanta 47
Hebei 46
Jiaxing 41
Shanghai 41
Guangzhou 39
Kunming 39
Foggia 37
London 37
Woodbridge 36
Changsha 35
Chicago 35
Orem 33
Frankfurt am Main 30
Brooklyn 27
Nuremberg 27
Zhengzhou 27
Milan 25
Brussels 24
San Francisco 24
Hangzhou 23
Hillsboro 23
Warsaw 23
Jinan 22
Baghdad 21
Assago 20
Xi'an 19
Rio de Janeiro 18
Seattle 18
Toronto 18
Montreal 17
Turku 17
Guayaquil 16
Tokyo 16
Bari 15
Chennai 15
Da Nang 15
Lanzhou 15
Norwalk 15
Rome 15
Tashkent 15
Boston 14
Falkenstein 14
Washington 14
Amsterdam 13
Buffalo 13
Haiphong 13
Hefei 13
Ningbo 13
Olomouc 13
Vienna 13
Johannesburg 12
Stockholm 12
Taizhou 12
Belo Horizonte 11
Hanover 11
Paris 11
Brasília 10
Curitiba 10
Mexico City 10
Naples 10
Noci 10
Pune 10
Salvador 10
San Severo 10
Totale 13.601
Salva come PNG Salva come JPEG
Nome #
Serious spondylodiscitis, septic sacroiliitis and multiple abscesses after ozone therapy for low back pain: A case report on good response to combined treatment with empiric antibiotic and neridronate 1.087
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 557
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 486
Primary versus systemic sclerosis-associated Raynaud’s phenomenon: relationship with clinical and environmental factors 220
A case of rhupus treated with filgotinib: A promising therapeutic perspective 202
Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns 196
SUBSTANCE P AND VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS DERIVING FROM PATIENTS WITH SYSTEMIC SCLEROSIS 161
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 160
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 158
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 156
Extra-skeletal effects of bisphosphonates. 155
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients? 152
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 148
Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. 148
Adult Scheuermann's disease as cause of mechanic dorsalgia 147
Nintedanib in Rheumatoid Arthritis–Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 145
Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis 144
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 144
Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis 142
Two cases of distal extremity swelling with pitting oedema in psoriatic arthritis: the different pathological mechanisms. 140
Pubic symphysis sclerosis in psoriatic arthritis. Case report. 139
Corticosteroids, a review. 134
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis 134
Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept. 133
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 132
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 131
Anti-TNF-α and risk of infections: the experience in one center. 131
Extracellular Matrix modulates angiogenesis in physiological and pathological conditions 128
Anomalies de la capillaroscopie périunguéale au cours de la fibrose pulmonaire associée à la sclérodermie systémique et au cours de la fibrose pulmonaire idiopathique 128
TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. 128
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. 128
COUNSELLING ON FAMILY PLANNING AND CONTRACEPTION, AND PREGNANCY OUTCOME IN WOMEN WITH RHEUMATIC DISEASES: A NATIONAL SURVEY OF 398 PATIENT-REPORTED QUESTIONNAIRES FROM 24 RHEUMATOLOGY CENTERS 128
Multiprofessional and intrahospital experience for diagnosis and treatment of pulmonary arterial hypertension 127
Role of altered osteoblastic expression of Dkk-1 in the pathogenesis of osteoarthritis and osteoporosis 126
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease. 126
Obesity and Chronic Inflammation: Implications for Rheumatoid Arthritis, Spondyloarthritis, and Ulcerative Colitis 125
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 125
Bisphosphonates: effects on osteoblast. 125
RANKL/OPG Ratio and DKK-1 Expression in Primary Osteoblastic Cultures from Osteoarthritic and Osteoporotic Subjects 125
Bone effects of biologic drugs in rheumatoid arthritis. 124
Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis 121
AB0171 Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 121
Comments on Addolorata Corrado et al. review “Extra-skeletal effects of bisphosphonates” 120
Mitochondrial disease mimicking polymyositis: a case report 119
La coxalgia 119
In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment 119
IgA nephropathy in systemic lupus erythematosus. 118
Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches 118
Adipokines and Chronic Rheumatic Diseases: from Inflammation to Bone Involvement 118
Anabolic therapy of induced osteoporosisin beta-thalassaemia major: case report and literature review 117
Metabolic effects of zoledronate on primary human osteoblastic cell cultures 117
Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report 116
Systemic effects of Wnt signaling 116
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 116
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 116
Bisphosphonates and osteoarthritis 116
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases 115
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 115
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 115
Osteocytes: central conductors of bone biology in normal and pathological conditions 114
Osteocalcin: Skeletal and extra-skeletal effects 114
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: A EUSTAR analysis 114
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 113
EFFECTS OF DIFFERENT ANTI TNF ALPHA TREATMENTS ON LIPID AND CARBOHYDRATE METABOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS 113
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database 113
THU0145 Changes in bone metabolism and trabecular bone score in patients with early rheumatoid arthritis 113
Intestinal histological and ultrastructural inflammatory changes in spondyloarthropathy and rheumatoid arthritis. 112
Integrine expression on human osteoblasts in osteoarthritis 112
SERUM 25(OH) VITAMIN D LEVELS, BODY MASS COMPOSITION AND EXTENT OF SKIN SCLEROSIS IN SYSTEMIC SCLEROSIS PATIENTS 112
Effects of Infliximab on human osteoblastic cells from rheumatoid arthrtis subjects 111
Osteoblast physiology in normal and pathological conditions 111
Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts. 111
Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis 111
Osteoblast as a target of anti-osteoporotic treatment 111
INHIBITORY EFFECT OF 1,25OH VITAMIN D ON IL-17 RELATED PRO-FIBROTIC CYTOKINES EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH SYSTEMIC SCLEROSIS 111
Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis 110
Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms 110
T cells support osteoclastogenesis in an in vitro model derived from human psoriatic arthritis 109
ANTI-CARBAMYLATED PROTEIN ANTIBODIES IN PATIENTS WITH SYSTEMIC SCLEROSIS: AN INTRIGUING ASSOCIATION WITH SKIN INVOLVEMENT 109
Reply to the letter by Baldeep Singh on the review entitled "Extra skeletal effects of bisphosphonates" 108
FRI0468 EFFECTS OF DIFFERENT VITAMIN D SUPPLEMENTATION SCHEMES IN POSTMENOPAUSAL WOMEN 108
Pathogenesis of ligaments ossification in spondyloarthritis: insights and doubts 107
AN EXEMPLAR BEHCET CASE, IN ALL ITS MULTISYSTEMIC FEATURES 107
Anti-angiogenic effects of anti–tumor necrosis factor α agents in the treatment of behçet disease 107
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? 107
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud’s phenomenon: a case–control study 107
Osteoporosis and rheumatic diseases 106
Neridronate and osteoporotic and ostearthitic human osteoblasts 106
AB1099 Counselling on family planning and contraception, and pregnancy outcome in women with rheumatic diseases: a national survey of 398 patient-reported questionnaires from 24 rheumatology centers 106
Impact of Systematic Isolation of Superior Vena Cava in Addition to Pulmonary Vein Antrum Isolation on the Outcome of Paroxysmal, Persistent, and Permanent Atrial Fibrillation Ablation: Results from a Randomized Study 105
Cervical myelopathy caused by periodontoid synovial pannus in a patient with psoriatic arthritis: a case report. 104
Successful treatment of avascular bone necrosis of the knee with neridronate: a case report 104
Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis 104
Glucocorticoid induced risk of fractures 104
Effects of Infliximab on human osteoblastic cells from rheumatoid arthritis subjects 104
Pathogenesis, clinical findings and management of acute and chronic gout. 104
Glucocorticoid induced risk of fractures. 103
Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis 103
Fibrosis mechanisms in systemic sclerosis and new potential therapies 102
Anti-cyclic-citrullinated-protein-antibodies in psoriatic arthritis patients: how autoimmune dysregulation could affect clinical characteristics, retention rate of methotrexate monotherapy and first line biotechnological drug survival. A single center retrospective study 102
Totale 14.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.681
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022728 0 0 9 9 65 18 28 72 134 125 34 234
2022/20233.674 325 162 171 154 189 326 20 306 1.791 30 95 105
2023/2024739 108 39 45 30 44 140 15 28 1 38 19 232
2024/20253.011 167 24 67 113 109 496 280 206 738 215 296 300
2025/20267.779 378 813 1.996 740 301 313 1.268 679 481 422 165 223
2026/20271.712 1.133 510 69 0 0 0 0 0 0 0 0 0
Totale 22.492